Journal of Human Hypertension, ISSN 0950-9240, 2018, Volume 33, Issue 10, pp. 741 - 747
White-coat uncontrolled hypertension (WUCH) and masked uncontrolled hypertension (MUCH) are common in the elderly. The prognostic role of these hypertension...
GENERAL-POPULATION | HOME BLOOD-PRESSURE | CARDIOVASCULAR EVENTS | CARDIAC STRUCTURE | RISK | PERIPHERAL VASCULAR DISEASE | PREVALENCE | TARGET ORGAN DAMAGE | INTERNATIONAL DATABASE | AWARENESS | EUROPEAN-SOCIETY | Hypertension | Medical research | Care and treatment | Prognosis | Medicine, Experimental | Aged | Health aspects | Phenotypes | Epidermal growth factor receptors | Medical prognosis | Mortality | Blood pressure | Patients | Geriatrics
GENERAL-POPULATION | HOME BLOOD-PRESSURE | CARDIOVASCULAR EVENTS | CARDIAC STRUCTURE | RISK | PERIPHERAL VASCULAR DISEASE | PREVALENCE | TARGET ORGAN DAMAGE | INTERNATIONAL DATABASE | AWARENESS | EUROPEAN-SOCIETY | Hypertension | Medical research | Care and treatment | Prognosis | Medicine, Experimental | Aged | Health aspects | Phenotypes | Epidermal growth factor receptors | Medical prognosis | Mortality | Blood pressure | Patients | Geriatrics
Journal Article
2.
Full Text
Effect of a Comprehensive Intervention on Plasma BDNF in Patients with Alzheimer’s Disease
Journal of Alzheimer's Disease, ISSN 1387-2877, 03/2017, Volume 57, Issue 1, pp. 37 - 43
A comprehensive intervention (CI) on patients with Alzheimer’s disease was assessed by measuring plasmabrain-derived neurotrophic factor (pBDNF) and ADAS-Cog...
Intervention | Homeostasis | Brain-derived neurotrophic factor | Alzheimer's disease | Patients | Cognitive ability
Intervention | Homeostasis | Brain-derived neurotrophic factor | Alzheimer's disease | Patients | Cognitive ability
Journal Article
Neurobiology of Learning and Memory, ISSN 1074-7427, 05/2019, Volume 161, pp. 83 - 91
A wide agreement exists that environmental enrichment (EE) is most beneficial if introduced early in life, but numerous studies reported that also aged animals...
Aging | Cognitive impairments | Environmental enrichment | Habituation | Aversive memory | Animal behavior | Memory | Cells
Aging | Cognitive impairments | Environmental enrichment | Habituation | Aversive memory | Animal behavior | Memory | Cells
Journal Article
High Blood Pressure and Cardiovascular Prevention, ISSN 1120-9879, 06/2017, Volume 24, Issue 2, pp. 115 - 126
Prevalence of cardiovascular (CV) disease is increasing worldwide. One of the most important risk factors for CV disease is hypertension that is very often...
Hypertension | Obesity | Cardiac natriuretic peptides | Metabolism | Cardiovascular risk | Natriuretic Peptide, Brain - therapeutic use | Cardiovascular Diseases - physiopathology | Prognosis | Risk Assessment | Signal Transduction | Receptors, Atrial Natriuretic Factor - metabolism | Cardiovascular Diseases - drug therapy | Humans | Risk Factors | Hypertension - drug therapy | Biomarkers - blood | Atrial Natriuretic Factor - blood | Hypertension - physiopathology | Hypertension - blood | Cardiovascular Agents - therapeutic use | Animals | Atrial Natriuretic Factor - therapeutic use | Cardiovascular Diseases - blood | Cardiovascular Diseases - epidemiology | Blood Pressure - drug effects | Hypertension - epidemiology | Natriuretic Peptide, Brain - blood
Hypertension | Obesity | Cardiac natriuretic peptides | Metabolism | Cardiovascular risk | Natriuretic Peptide, Brain - therapeutic use | Cardiovascular Diseases - physiopathology | Prognosis | Risk Assessment | Signal Transduction | Receptors, Atrial Natriuretic Factor - metabolism | Cardiovascular Diseases - drug therapy | Humans | Risk Factors | Hypertension - drug therapy | Biomarkers - blood | Atrial Natriuretic Factor - blood | Hypertension - physiopathology | Hypertension - blood | Cardiovascular Agents - therapeutic use | Animals | Atrial Natriuretic Factor - therapeutic use | Cardiovascular Diseases - blood | Cardiovascular Diseases - epidemiology | Blood Pressure - drug effects | Hypertension - epidemiology | Natriuretic Peptide, Brain - blood
Journal Article
Atherosclerosis, ISSN 0021-9150, 08/2017, Volume 263, pp. e189 - e189
Journal Article
Journal of Hypertension, ISSN 0263-6352, 11/2017, Volume 35, Issue 11, pp. 2315 - 2322
Angiotensin-converting enzyme inhibitors (ACE-I) and AT1 blockers (ARB) are commonly used antihypertensive drugs, but several factors may affect their...
pulse pressure | plasma renin activity | plasma aldosterone concentration | ambulatory blood pressure measurement | night-time blood pressure | blood pressure control | hypertension | Blood Pressure | Angiotensin II Type 1 Receptor Blockers - therapeutic use | Humans | Middle Aged | Aldosterone - blood | Male | Biomarkers - blood | Circadian Rhythm | Renin - blood | Essential Hypertension - physiopathology | Essential Hypertension - drug therapy | Angiotensin-Converting Enzyme Inhibitors - therapeutic use | Essential Hypertension - blood | Female | Renin-Angiotensin System - drug effects | Blood Pressure Monitoring, Ambulatory
pulse pressure | plasma renin activity | plasma aldosterone concentration | ambulatory blood pressure measurement | night-time blood pressure | blood pressure control | hypertension | Blood Pressure | Angiotensin II Type 1 Receptor Blockers - therapeutic use | Humans | Middle Aged | Aldosterone - blood | Male | Biomarkers - blood | Circadian Rhythm | Renin - blood | Essential Hypertension - physiopathology | Essential Hypertension - drug therapy | Angiotensin-Converting Enzyme Inhibitors - therapeutic use | Essential Hypertension - blood | Female | Renin-Angiotensin System - drug effects | Blood Pressure Monitoring, Ambulatory
Journal Article
Journal of Alzheimer's Disease, ISSN 1387-2877, 02/2016, Volume 50, Issue 4, pp. 957 - 962
We evaluated the effect of cognitive stimulation (CS) on platelet total phospholipases A2 activity (tPLA2A) in patients with mild cognitive impairment (MCI_P)....
cognitive stimulation | mild cognitive impairment | Blood platelets | phospholipases A2 | Neuropsychological Tests | Phospholipases A2 - blood | Blood Platelets - metabolism | Humans | Cognitive Dysfunction - therapy | Cognition - physiology | Mental Status Schedule | Cognitive Therapy | Treatment Outcome | Cognitive Dysfunction - blood | Cohort Studies
cognitive stimulation | mild cognitive impairment | Blood platelets | phospholipases A2 | Neuropsychological Tests | Phospholipases A2 - blood | Blood Platelets - metabolism | Humans | Cognitive Dysfunction - therapy | Cognition - physiology | Mental Status Schedule | Cognitive Therapy | Treatment Outcome | Cognitive Dysfunction - blood | Cohort Studies
Journal Article
8.
Full Text
Effect of a Comprehensive Intervention on Plasma BDNF in Patients with Alzheimer's Disease
Journal of Alzheimer's Disease, ISSN 1387-2877, 2017, Volume 57, Issue 1, pp. 37 - 43
A comprehensive intervention (CI) on patients with Alzheimer's disease was assessed by measuring plasma brain-derived neurotrophic factor (pBDNF) and ADAS-Cog...
comprehensive intervention | brain-derived neurotrophic factor | time | plasma | Alzheimer disease | DEMENTIA | STIMULATION | NEUROTROPHIC FACTOR LEVELS | HUMAN PLATELETS | RISK | brain | MILD COGNITIVE IMPAIRMENT | VAL66MET POLYMORPHISM | NEUROSCIENCES | derived neurotrophic factor | SERUM CONCENTRATIONS | BLOOD-BRAIN | AGE | Follow-Up Studies | Humans | Alzheimer Disease - therapy | Female | Male | Treatment Outcome | Aged | Brain-Derived Neurotrophic Factor - blood | Biomarkers - blood | Alzheimer Disease - blood
comprehensive intervention | brain-derived neurotrophic factor | time | plasma | Alzheimer disease | DEMENTIA | STIMULATION | NEUROTROPHIC FACTOR LEVELS | HUMAN PLATELETS | RISK | brain | MILD COGNITIVE IMPAIRMENT | VAL66MET POLYMORPHISM | NEUROSCIENCES | derived neurotrophic factor | SERUM CONCENTRATIONS | BLOOD-BRAIN | AGE | Follow-Up Studies | Humans | Alzheimer Disease - therapy | Female | Male | Treatment Outcome | Aged | Brain-Derived Neurotrophic Factor - blood | Biomarkers - blood | Alzheimer Disease - blood
Journal Article
The Journal of Clinical Hypertension, ISSN 1524-6175, 09/2018, Volume 20, Issue 9, pp. 1230 - 1237
Blood pressure (BP) changes and risk factors associated with pulse pressure (PP) increase in elderly people have rarely been studied using ambulatory blood...
ambulatory blood pressure monitoring | aging | ambulatory pulse pressure | blood pressure control | elderly | MORTALITY | METAANALYSIS | ADULTS | NIGHTTIME | FOLLOW-UP | RISK | PREVALENCE | HYPERTENSIVE PATIENTS | OLDER PATIENTS | PERIPHERAL VASCULAR DISEASE | AGE | Measurement | Hypertension | Blood pressure | Aged | Patient compliance | Mortality
ambulatory blood pressure monitoring | aging | ambulatory pulse pressure | blood pressure control | elderly | MORTALITY | METAANALYSIS | ADULTS | NIGHTTIME | FOLLOW-UP | RISK | PREVALENCE | HYPERTENSIVE PATIENTS | OLDER PATIENTS | PERIPHERAL VASCULAR DISEASE | AGE | Measurement | Hypertension | Blood pressure | Aged | Patient compliance | Mortality
Journal Article
Journal of the American Medical Directors Association, ISSN 1525-8610, 04/2018, Volume 19, Issue 4, pp. 342 - 347
Objectives: Cardiovascular diseases are mainly related to hypertension and dyslipidemia and increase with aging because of the larger time span for these risk...
cardiovascular drug | in-hospital mortality | Very elderly | comorbidity | RAAS inhibition | statin | OLDER-ADULTS | HEART-FAILURE | RECEPTOR BLOCKERS | CONVERTING ENZYME-INHIBITORS | PREVALENCE | BLOOD-PRESSURE | CARE | GERIATRICS & GERONTOLOGY | THERAPY | OUTCOMES | BENEFITS
cardiovascular drug | in-hospital mortality | Very elderly | comorbidity | RAAS inhibition | statin | OLDER-ADULTS | HEART-FAILURE | RECEPTOR BLOCKERS | CONVERTING ENZYME-INHIBITORS | PREVALENCE | BLOOD-PRESSURE | CARE | GERIATRICS & GERONTOLOGY | THERAPY | OUTCOMES | BENEFITS
Journal Article
11.
Trisomy of the Short Arm of Chromosome 12 Associated with High Cardiovascular Risk: A Case Report
High blood pressure & cardiovascular prevention : the official journal of the Italian Society of Hypertension, 04/2019, Volume 26, Issue 2, p. 143
Trisomy of the short arm of chromosome 12 is a rare genetic disease characterised by dysmorphic features, mental retardation, behavioural disorders, seizures...
Journal Article
The Journal of Clinical Hypertension, ISSN 1524-6175, 05/2017, Volume 19, Issue 5, pp. 472 - 478
Patients with type 2 diabetes mellitus are at high risk for atherosclerotic disease, and proper blood pressure measurement is mandatory. The authors examined...
atherosclerosis | diabetes mellitus | cardiovascular risk factors | Interarm difference | hypertension | MORTALITY | MANAGEMENT | GUIDELINES | RISK MARKER | ALL-CAUSE | COMMUNITY | DISEASE | PERIPHERAL VASCULAR DISEASE | ARM DIFFERENCE | ASSOCIATION | Predictive Value of Tests | Prevalence | Humans | Middle Aged | Male | Diabetic Retinopathy - complications | Diabetic Retinopathy - physiopathology | Diabetic Nephropathies - physiopathology | Systole - physiology | Aged, 80 and over | Cardiovascular Diseases - epidemiology | Female | Blood Pressure - physiology | Diabetes Mellitus, Type 2 - complications | Atherosclerosis - physiopathology | Risk Factors | Atherosclerosis - complications | Hypertension - physiopathology | Blood Pressure Determination - methods | Diabetic Nephropathies - complications | Diabetes Mellitus, Type 2 - physiopathology | Hypertrophy, Left Ventricular - complications | Arm - blood supply | Aged | Hypertrophy, Left Ventricular - physiopathology | Type 2 diabetes | Hypertension | Diabetics | Blood pressure
atherosclerosis | diabetes mellitus | cardiovascular risk factors | Interarm difference | hypertension | MORTALITY | MANAGEMENT | GUIDELINES | RISK MARKER | ALL-CAUSE | COMMUNITY | DISEASE | PERIPHERAL VASCULAR DISEASE | ARM DIFFERENCE | ASSOCIATION | Predictive Value of Tests | Prevalence | Humans | Middle Aged | Male | Diabetic Retinopathy - complications | Diabetic Retinopathy - physiopathology | Diabetic Nephropathies - physiopathology | Systole - physiology | Aged, 80 and over | Cardiovascular Diseases - epidemiology | Female | Blood Pressure - physiology | Diabetes Mellitus, Type 2 - complications | Atherosclerosis - physiopathology | Risk Factors | Atherosclerosis - complications | Hypertension - physiopathology | Blood Pressure Determination - methods | Diabetic Nephropathies - complications | Diabetes Mellitus, Type 2 - physiopathology | Hypertrophy, Left Ventricular - complications | Arm - blood supply | Aged | Hypertrophy, Left Ventricular - physiopathology | Type 2 diabetes | Hypertension | Diabetics | Blood pressure
Journal Article
Annals of the New York Academy of Sciences, ISSN 0077-8923, 06/2004, Volume 1019, Issue 1, pp. 44 - 47
: The effect of chronic aluminium administration (2 g/L/6 months) was investigated in the central nervous system (CNS) of old rats. The content of Al3+, Cu2+,...
Timm's reaction | hippocampus | aluminum administration | Alzheimer disease | brain metal ions | Brain metal ions | Aluminum administration | Hippocampus | MULTIDISCIPLINARY SCIENCES | NEURONAL INJURY | Oxidative Stress | Rats, Wistar | Mesencephalon - metabolism | Cerebellum - metabolism | Aluminum - pharmacology | Copper - pharmacology | Rats | Male | Hippocampus - pathology | Alzheimer Disease | Brain - drug effects | Hippocampus - metabolism | Animals | Brain - pathology | Pons - metabolism | Prosencephalon - metabolism | Zinc - pharmacology | Manganese - pharmacology
Timm's reaction | hippocampus | aluminum administration | Alzheimer disease | brain metal ions | Brain metal ions | Aluminum administration | Hippocampus | MULTIDISCIPLINARY SCIENCES | NEURONAL INJURY | Oxidative Stress | Rats, Wistar | Mesencephalon - metabolism | Cerebellum - metabolism | Aluminum - pharmacology | Copper - pharmacology | Rats | Male | Hippocampus - pathology | Alzheimer Disease | Brain - drug effects | Hippocampus - metabolism | Animals | Brain - pathology | Pons - metabolism | Prosencephalon - metabolism | Zinc - pharmacology | Manganese - pharmacology
Journal Article
Annals of the New York Academy of Sciences, ISSN 0077-8923, 06/2004, Volume 1019, pp. 44 - 47
The effect of chronic aluminium administration (2 g/L/6 months) was investigated in the central nervous system (CNS) of old rats. The content of Al super(3+),...
Journal Article
Journal of Alzheimer's Disease, ISSN 1387-2877, 2003, Volume 5, Issue 6, pp. 437 - 444
The effect of chronic aluminum intake has been investigated in the brain of aged male Wistar rats to assess the potential role of the accumulation of this...
NEUROSCIENCES | Rats, Wistar | Zinc - metabolism | Aluminum - pharmacology | Cerebellum - drug effects | Male | Medulla Oblongata - chemistry | Hippocampus - drug effects | Prosencephalon - chemistry | Pons - chemistry | Prosencephalon - drug effects | Manganese - analysis | Zinc - analysis | Pyramidal Cells - chemistry | Copper - metabolism | Mesencephalon - drug effects | Pyramidal Cells - drug effects | Aluminum - blood | Medulla Oblongata - drug effects | Pons - drug effects | Rats | Hippocampus - pathology | Mesencephalon - chemistry | Brain - drug effects | Aluminum - administration & dosage | Animals | Copper - analysis | Manganese - metabolism | Aging - physiology | Pyramidal Cells - pathology | Cerebellum - chemistry | Aggression - drug effects
NEUROSCIENCES | Rats, Wistar | Zinc - metabolism | Aluminum - pharmacology | Cerebellum - drug effects | Male | Medulla Oblongata - chemistry | Hippocampus - drug effects | Prosencephalon - chemistry | Pons - chemistry | Prosencephalon - drug effects | Manganese - analysis | Zinc - analysis | Pyramidal Cells - chemistry | Copper - metabolism | Mesencephalon - drug effects | Pyramidal Cells - drug effects | Aluminum - blood | Medulla Oblongata - drug effects | Pons - drug effects | Rats | Hippocampus - pathology | Mesencephalon - chemistry | Brain - drug effects | Aluminum - administration & dosage | Animals | Copper - analysis | Manganese - metabolism | Aging - physiology | Pyramidal Cells - pathology | Cerebellum - chemistry | Aggression - drug effects
Journal Article
Molecular Neurobiology, ISSN 0893-7648, 8/2018, Volume 55, Issue 8, pp. 6661 - 6672
Mounting evidence that alterations in brain-derived neurotrophic factor (BDNF) levels and signaling may be involved in the etiopathogenesis of Alzheimer’s...
Neurology | Neurosciences | Biomarker | Biomedicine | Brain-derived neurotrophic factor | Alzheimer’s disease | Neurobiology | Confounding variables | Blood | Cell Biology | Brain | Neurodegenerative diseases | Peripheral blood | Dementia disorders | Mental depression | Alzheimer's disease | Blood levels
Neurology | Neurosciences | Biomarker | Biomedicine | Brain-derived neurotrophic factor | Alzheimer’s disease | Neurobiology | Confounding variables | Blood | Cell Biology | Brain | Neurodegenerative diseases | Peripheral blood | Dementia disorders | Mental depression | Alzheimer's disease | Blood levels
Journal Article
No results were found for your search.
Cannot display more than 1000 results, please narrow the terms of your search.